These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6152317)

  • 1. Physical dependence induced by opiate partial agonists in the rat.
    McCarthy PS; Howlett GJ
    Neuropeptides; 1984 Dec; 5(1-3):11-4. PubMed ID: 6152317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity to the effects of opioids in rats with free access to exercise wheels: mu-opioid tolerance and physical dependence.
    Smith MA; Yancey DL
    Psychopharmacology (Berl); 2003 Aug; 168(4):426-34. PubMed ID: 12709780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An examination of the interactions between the antinociceptive effects of morphine and various mu-opioids: the role of intrinsic efficacy and stimulus intensity.
    Morgan D; Cook CD; Smith MA; Picker MJ
    Anesth Analg; 1999 Feb; 88(2):407-13. PubMed ID: 9972766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substitution and primary dependence studies in animals.
    Woods JH; Gmerek DE
    Drug Alcohol Depend; 1985 Feb; 14(3-4):233-47. PubMed ID: 4039649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nalbuphine.
    Schmidt WK; Tam SW; Shotzberger GS; Smith DH; Clark R; Vernier VG
    Drug Alcohol Depend; 1985 Feb; 14(3-4):339-62. PubMed ID: 2986929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex-related differences in the antinociceptive effects of opioids: importance of rat genotype, nociceptive stimulus intensity, and efficacy at the mu opioid receptor.
    Cook CD; Barrett AC; Roach EL; Bowman JR; Picker MJ
    Psychopharmacology (Berl); 2000 Jul; 150(4):430-42. PubMed ID: 10958085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between an N-methyl-D-aspartate antagonist and low-efficacy opioid receptor agonists in assays of schedule-controlled responding and thermal nociception.
    Fischer BD; Dykstra LA
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1300-6. PubMed ID: 16772537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist and antagonist properties of buprenorphine, a new antinociceptive agent.
    Cowan A; Lewis JW; Macfarlane IR
    Br J Pharmacol; 1977 Aug; 60(4):537-45. PubMed ID: 409448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-administration of nalbuphine, butorphanol and pentazocine by morphine post-addict rats.
    Steinfels GF; Young GA; Khazan N
    Pharmacol Biochem Behav; 1982 Jan; 16(1):167-71. PubMed ID: 7199184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid agonist-antagonist drugs in acute and chronic pain states.
    Hoskin PJ; Hanks GW
    Drugs; 1991 Mar; 41(3):326-44. PubMed ID: 1711441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of morphine, naloxone, buprenorphine, butorphanol, haloperidol and imipramine on morphine withdrawal signs in cynomolgus monkeys.
    Fukase H; Fukuzaki K; Koja T; Nagata R; Lukas SE
    Psychopharmacology (Berl); 1994 Dec; 116(4):396-400. PubMed ID: 7701039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buprenorphrine: demonstration of physical dependence liability.
    Dum J; Bläsig J; Herz A
    Eur J Pharmacol; 1981 Mar; 70(3):293-300. PubMed ID: 6262095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The physical dependence liability of butorphanol: a comparative study with morphine.
    Horan P; Ho IK
    Eur J Pharmacol; 1991 Oct; 203(3):387-91. PubMed ID: 1773823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of gonadectomy on the antinociceptive effects of opioids in male and female rats.
    Terner JM; Barrett AC; Grossell E; Picker MJ
    Psychopharmacology (Berl); 2002 Sep; 163(2):183-93. PubMed ID: 12202965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Butorphanol precipitates abstinence in morphine dependent rats.
    Horan P; Ho IK
    Eur J Pharmacol; 1989 Nov; 170(3):265-8. PubMed ID: 2620698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Social and environmental influences on opioid sensitivity in rats: importance of an opioid's relative efficacy at the mu-receptor.
    Smith MA; Chisholm KA; Bryant PA; Greene JL; McClean JM; Stoops WW; Yancey DL
    Psychopharmacology (Berl); 2005 Aug; 181(1):27-37. PubMed ID: 15778888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The enflurane sparing effect of morphine, butorphanol, and nalbuphine.
    Murphy MR; Hug CC
    Anesthesiology; 1982 Dec; 57(6):489-92. PubMed ID: 7149306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple, reliable method for predicting the physical dependence liability of narcotic antagonist analgesics in the rat.
    Howes JF
    Pharmacol Biochem Behav; 1981 May; 14(5):689-92. PubMed ID: 6113607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nociceptive sensitivity and opioid antinociception and antihyperalgesia in Freund's adjuvant-induced arthritic male and female rats.
    Cook CD; Nickerson MD
    J Pharmacol Exp Ther; 2005 Apr; 313(1):449-59. PubMed ID: 15608071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminative stimulus effects of buprenorphine in the rat.
    Holtzman SG
    Psychopharmacology (Berl); 1997 Apr; 130(3):292-9. PubMed ID: 9151365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.